Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.862 USD | +0.19% | -16.17% | -33.07% |
Apr. 25 | OptiNose, Inc. Provides Revenue Guidance for the First Quarter of 2024 | CI |
Apr. 25 | Transcript : OptiNose, Inc. - Special Call |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 422.7 | 215.6 | 133.2 | 203.2 | 144.9 | 97.26 | - | - |
Enterprise Value (EV) 1 | 422.7 | 215.6 | 133.2 | 203.2 | 144.9 | 97.26 | 97.26 | 97.26 |
P/E ratio | -3.51 x | -2 x | -1.12 x | -2.13 x | -4.03 x | -3.31 x | -8.6 x | 10.8 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 12.2 x | 4.39 x | 1.78 x | 2.66 x | 2.04 x | 1.06 x | 0.75 x | 0.63 x |
EV / Revenue | 12.2 x | 4.39 x | 1.78 x | 2.66 x | 2.04 x | 1.06 x | 0.75 x | 0.63 x |
EV / EBITDA | -4.99 x | -2.51 x | -2.02 x | -3.67 x | -6.48 x | -24.3 x | 7.66 x | 3.01 x |
EV / FCF | -4.47 x | -2.49 x | -1.73 x | - | - | -69.1 x | 9.96 x | 5.03 x |
FCF Yield | -22.4% | -40.2% | -57.9% | - | - | -1.45% | 10% | 19.9% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 45,842 | 52,081 | 82,200 | 109,840 | 112,312 | 113,039 | - | - |
Reference price 2 | 9.220 | 4.140 | 1.620 | 1.850 | 1.290 | 0.8604 | 0.8604 | 0.8604 |
Announcement Date | 3/5/20 | 3/3/21 | 3/8/22 | 3/7/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 34.63 | 49.12 | 74.65 | 76.28 | 70.99 | 90.46 | 130.2 | 158.6 |
EBITDA 1 | -84.63 | -85.76 | -65.8 | -55.36 | -22.35 | -4.004 | 12.69 | 32.33 |
EBIT 1 | -95.6 | -87.22 | -66.45 | -55.9 | -22.75 | -11.77 | 7.458 | 26.19 |
Operating Margin | -276.06% | -177.57% | -89.01% | -73.28% | -32.05% | -13.01% | 5.73% | 16.51% |
Earnings before Tax (EBT) 1 | -110.1 | -99.79 | -82.3 | -74.83 | -35.48 | -30.54 | -12.97 | 23.42 |
Net income 1 | -110.1 | -99.79 | -82.3 | -74.83 | -35.48 | -30.54 | -12.97 | 22.26 |
Net margin | -317.79% | -203.16% | -110.24% | -98.11% | -49.99% | -33.76% | -9.96% | 14.03% |
EPS 2 | -2.630 | -2.070 | -1.450 | -0.8700 | -0.3200 | -0.2600 | -0.0875 | 0.0900 |
Free Cash Flow 1 | -94.59 | -86.75 | -77.1 | - | - | -1.327 | 14.9 | 22.7 |
FCF margin | -273.15% | -176.62% | -103.28% | - | - | -1.47% | 11.45% | 14.31% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | 117.42% | 70.23% |
FCF Conversion (Net income) | - | - | - | - | - | - | - | 102.01% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/5/20 | 3/3/21 | 3/8/22 | 3/7/23 | 3/7/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 21.83 | 22.51 | 14.76 | 20.58 | 20.08 | 20.86 | 11.85 | 19.45 | 19.82 | 19.86 | 13.03 | 21.47 | 25.41 | 33.63 | 24.5 |
EBITDA | -12.89 | -11.5 | -19.28 | - | - | -8.224 | - | - | - | - | - | - | - | - | - |
EBIT 1 | -13.04 | -11.67 | -21.4 | -15.34 | -10.8 | -8.356 | -14.37 | -4.172 | -1.694 | -2.512 | -8.787 | -5.4 | -1.503 | 3.334 | -3 |
Operating Margin | -59.75% | -51.84% | -144.95% | -74.56% | -53.79% | -40.07% | -121.29% | -21.45% | -8.55% | -12.65% | -67.42% | -25.15% | -5.91% | 9.91% | -12.24% |
Earnings before Tax (EBT) 1 | -17.12 | -15.62 | -25.33 | -19.4 | -14.95 | -15.15 | -18.85 | 2.626 | -9.294 | -9.967 | -13.36 | -10.05 | -6.137 | -1.283 | -7.7 |
Net income 1 | -17.12 | -15.62 | -25.33 | -19.4 | -14.95 | -15.15 | -18.85 | 2.573 | -9.294 | -9.967 | -13.36 | -10.05 | -6.137 | -1.283 | -7.7 |
Net margin | -78.42% | -69.41% | -171.63% | -94.24% | -74.48% | -72.64% | -159.1% | 13.23% | -46.88% | -50.17% | -102.49% | -46.83% | -24.15% | -3.81% | -31.43% |
EPS 2 | -0.3200 | -0.2300 | -0.3100 | -0.2300 | -0.1800 | -0.1700 | -0.1700 | 0.0200 | -0.0800 | -0.0900 | -0.1100 | -0.0825 | -0.0550 | -0.0150 | -0.0600 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/15/21 | 3/8/22 | 5/12/22 | 8/11/22 | 11/10/22 | 3/7/23 | 5/11/23 | 8/10/23 | 11/9/23 | 3/7/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | -94.6 | -86.8 | -77.1 | - | - | -1.41 | 9.77 | 19.3 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 0.56 | 0.55 | 0.17 | 0.06 | 0.33 | 0.41 | 0.41 | 0.41 |
Capex / Sales | 1.61% | 1.11% | 0.22% | 0.08% | 0.46% | 0.45% | 0.32% | 0.27% |
Announcement Date | 3/5/20 | 3/3/21 | 3/8/22 | 3/7/23 | 3/7/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.07% | 97.26M | |
+25.95% | 661B | |
+26.74% | 566B | |
-6.65% | 352B | |
+19.35% | 332B | |
+3.36% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.17% | 145B |
- Stock Market
- Equities
- OPTN Stock
- Financials OptiNose, Inc.